Comparing infrared neuromodulation (IRN) with isotonic glucose solution for selective inhibition of small-diameter axons  (Conference Presentation)

Junqi Zhuo; Matthew T. McPheeters; Elizabeth M. Jackson; Sachin S. Shankar; Mohit Ganguly; E. D. Jansen; Hillel J. Chiel; Michael W. Jenkins

doi:10.1117/12.2510417

7 March 2019 Comparing infrared neuromodulation (IRN) with isotonic glucose solution for selective inhibition of small-diameter axons (Conference Presentation)

Junqi Zhuo, Matthew T. McPheeters, Elizabeth M. Jackson, Sachin S. Shankar, Mohit Ganguly, E. D. Jansen, Hillel J. Chiel, Michael W. Jenkins

Author Affiliations +

Proceedings Volume 10866, Optogenetics and Optical Manipulation 2019; 108660O (2019) https://doi.org/10.1117/12.2510417
Event: SPIE BiOS, 2019, San Francisco, California, United States

Abstract

Neuromodulation has the potential to treat various diseases (i.e., heart failure, obesity). Several clinical trials have recently failed because of the inability to modulate small-diameter fibers. Previously, we demonstrated preferential inhibition of small-diameter fibers using infrared neuromodulation (IRN). To understand the mechanism of action, we did a mathematical analysis which suggested that any modality acting primarily on the axonal surface would preferentially affect small-diameter axons. To test our hypothesis, we examined whether isotonic glucose solution would give results similar to IRN. We stimulated the left and right pleural-abdominal connective nerves of Aplysia californica and recorded the resulting compound action potentials (CAPs). We designed a chamber with three isolated compartments through which the nerve passes sequentially. Aplysia saline is perfused in the two outer chambers while the middle chamber can be perfused with either Aplysia saline or an isotonic glucose solution (10.21 w/v %). The width of the middle chamber is adjustable to vary the length of nerve perfused by the isotonic glucose solution. As the length of the middle chamber increases, recorded CAPs are initially unaffected, then show a loss of peaks representing small-diameter axons, then show no activity. We can restore full, unchanged CAPs by washing out the glucose solution and replacing it with Aplysia saline. These results support the hypothesis that any modality (e.g., both IRN and isotonic glucose solution) acting primarily on the axonal surface would preferentially affect small-diameter axons. Future studies will compare IRN with isotonic glucose block.

Conference Presentation

Citation Download Citation

Junqi Zhuo, Matthew T. McPheeters, Elizabeth M. Jackson, Sachin S. Shankar, Mohit Ganguly, E. D. Jansen, Hillel J. Chiel, and Michael W. Jenkins "Comparing infrared neuromodulation (IRN) with isotonic glucose solution for selective inhibition of small-diameter axons (Conference Presentation)", Proc. SPIE 10866, Optogenetics and Optical Manipulation 2019, 108660O (7 March 2019); https://doi.org/10.1117/12.2510417

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

Glucose

Axons

Infrared radiation

Nerve

Action potentials

Clinical trials

Failure analysis

Show All Keywords

Keywords/Phrases

Search In:

Publication Years